Nutrien AI Stock Analysis
Nutrien (N7T) AI Stock Analysis
Nutrien
(XETRA:N7T)
No summary available
Nutrien (N7T) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 34.12B
- Dividend Yield
- 2.99%
- Average Volume (3M)
- 246
- Price to Earnings (P/E)
- 15.6
- Beta (1Y)
- 0.24
- Revenue Growth
- 1.54%
- EPS Growth
- 20.75%
- Country
- Germany
- Employees
- 25,500
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Agricultural Inputs
Nutrien Business Overview & Revenue Model
Company Description
Nutrien Ltd. is a prominent agricultural company dedicated to supplying crucial crop inputs and comprehensive services to the farming sector. It specializes in the production and provision of essential plant nutrients like potash, nitrogen, phosphate...
Nutrien Earnings Call Summary
The call was broadly positive. Nutrien reported strong adjusted EBITDA, a 17% increase in operating cash flow, higher shareholder returns, raised potash and nitrogen volume guidance, operational improvements, and supportive potash and nitrogen market fundamentals. The principal challenges were weaker third-quarter retail performance, Brazil rationalization, elevated sulfur costs and phosphate affordability issues, and supply-chain and geopolitical uncertainty. Management nevertheless presented these issues alongside specific corrective actions and maintained a constructive outlook for 2027.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Nutrien maintained its forecast for global potash shipments of 74 million-77 million tons in 2026 and forecast global potash shipments of 75 million-79 million tons in 2027, raised full-year potash sales volume guidance range to 14.3 million-14.8 million tons and full-year nitrogen sales volume guidance range to 9.3 million-9.7 million tons, expects ammonia operating rates above 95% in the fourth quarter, a moderate increase in fourth-quarter phosphate sales volumes and margins, upstream fertilizer sales volumes to increase by approximately 600,000 tons year-over-year on a like-for-like asset basis, and revised full-year retail adjusted EBITDA guidance range to $1.72 billion-$1.85 billion; it expects mid-single-digit annual growth rates in Retail, mid to high single digits growth for proprietary gross margin on a full-year basis for 2026, stronger North American fall fertilizer application season with a normal fall application window, nitrogen fundamentals to remain tight into 2027, strong demand early in 2027, global potash demand growth in line with historical consumption trends, limited new potash operational capacity in 2027, nitrogen operating rates to reach 91%, potash capacity for 15 million-16 million tons with the ability to get to 19 million tons at $200-$300 a ton in terms of CapEx, and a moderately negative EBITDA contribution from Brazil in 2026.
Nutrien Peers Comparison
Overall Rating
TSE:IFOS54Neutral
TSE:KRN47Neutral
TSE:NPK41Neutral
TSE:MGRO39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 54Neutral | CAD 344.76M | 13.86 | 4.12% | ― | 5.77% | -86.18% | |
| 47Neutral | CAD 14.39M | -18.98 | -21.18% | ― | ― | 28.27% | |
| 41Neutral | CAD 33.30M | -2.37 | -71.66% | ― | -28.84% | -18.04% | |
| 39Underperform | CAD 27.82M | -4.02 | -218.75% | ― | -54.59% | 10.76% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:N7T | Nutrien | 64.38 | 14.24 | 28.41% | |
| TSE:KRN | Karnalyte Resources | 0.26 | 0.14 | 116.67% | |
| TSE:NPK | Verde Agritech | 0.59 | -0.31 | -34.44% | |
| TSE:IFOS | Itafos Inc | 1.79 | -1.65 | -47.97% | |
| TSE:MGRO | Mustgrow Biologics Corp. | 0.39 | -0.25 | -39.06% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
